Short-term medical management of hydrocephalus

Expert Opinion on Pharmacotherapy

Volumn 6, Issue 9, 2005, Pages 1525-1538

  Poca, Maria A ^a   Sahuquillo, Juan ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Acetazolamide; Carbonic anhydrase; Furosemide; Hydrocephalus; Intraventricular fibrinolytic therapy; Medical treatment

Indexed keywords

ACETAZOLAMIDE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALTEPLASE; BICARBONATE; CARBONATE DEHYDRATASE INHIBITOR; CHLORIDE; DEXAMETHASONE; DIGOXIN; FIBRINOLYTIC AGENT; FUROSEMIDE; GLYCEROL; ISOSORBIDE; LOOP DIURETIC AGENT; MANNITOL; OSMOTIC DIURETIC AGENT; OUABAIN; POTASSIUM; POTASSIUM CHLORIDE; STREPTOKINASE; UREA; UROKINASE;

ANOREXIA; BLEEDING; BLOOD CLOT LYSIS; BRAIN BLOOD FLOW; BRAIN VENTRICLE PERITONEUM SHUNT; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID SHUNTING; CLINICAL TRIAL; DIARRHEA; DOG; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG HALF LIFE; DRUG INDICATION; DRUG MECHANISM; DRUG UTILIZATION; ELECTROLYTE DISTURBANCE; ENZYME INHIBITION; EVIDENCE BASED MEDICINE; FEEDING DISORDER; HUMAN; HYDROCEPHALUS; HYPERCHLOREMIA; HYPOKALEMIA; HYPOTENSION; INCIDENCE; INFECTION; INTRACRANIAL PRESSURE; KIDNEY CALCIFICATION; LETHARGY; LUMBAR PUNCTURE; META ANALYSIS; NONHUMAN; OSTEOPENIA; PARESTHESIA; PATIENT MONITORING; REVIEW; SHORT COURSE THERAPY; SYSTEMATIC REVIEW; TACHYPNEA; TREATMENT OUTCOME; VENTRICULOATRIAL SHUNT; VOMITING;

ACETAZOLAMIDE; ANIMALS; CARBONIC ANHYDRASE INHIBITORS; CEREBROSPINAL FLUID SHUNTS; CEREBROVASCULAR CIRCULATION; COMBINED MODALITY THERAPY; DIURETICS; DRUG THERAPY, COMBINATION; FUROSEMIDE; HUMANS; HYDROCEPHALUS; INTRACRANIAL PRESSURE; ISOSORBIDE; RANDOMIZED CONTROLLED TRIALS; THROMBOLYTIC THERAPY; TIME FACTORS; VENTRICULOSTOMY;

EID: 23644436537     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.6.9.1525     Document Type: Review

References (100)

1. WANG PP, AVELLINO AM: Hydrocephalus in children. In: Principles of neurosurgery. Rengachary SS, Ellenbogen RG (Eds), Elsevier Mosby, Edinburgh (2005):117-135.
2. STEIN SC: Hydrocephalus in adults. In: Principles of neurosurgery. Rengachary SS, Ellenbogen RG (Eds), Elsevier Mosby, Edinburgh (2005):137-143.
3. POCA MA, SAHUQUILLO J, MATARO M: [Update on diagnosis and treatment of normotensive hydrocephalus (chronic hydrocephalus of the adult)]. Neurologia (2001) 16:353-369.
4. POCA MA, MATARO M, MATARIN M, ARIKAN F, JUNQUE C, SAHUQUILLO J: Is shunting patients with idiopathic normal-pressure hydrocephalus syndrome worth the risk? Results of a study based on continuous monitoring of intracranial pressure. J. Neurosurg. (2004) 100:855-866.
5. SOOD S, HAM SD, CANADY AI: Current treatment of hydrocephalus. Neurosurgery Quarterly (2001) 11:36-44.
6. GILMORE HE: Medical treatment of hydrocephalus. In: Hydrocephalus (Vol. 3). Scott RM (Ed.), Williams & Wilkins, Baltimore (1990):37-46.
7. LAURENCE KM, COATES S: Spontaneously arrested hydrocephalus. Results of the reexamination of 82 survivors from a series of 182 unoperated cases. Dev. Med. Child Neurol. (1967) Suppl. 13:4-13.
8. FOLTZ EL, SHURTLEFF DB: Five-year comparative study of hydrocephalus in children with and whitout operation (113 cases). J. Neurosurg. (1963) 20:1064-1079.
9. MCCULLOUGH DC: History of the treatment of hydrocephalus. In: Hydrocephalus (Vol. 3). Scott RM (Ed.), Williams & Wilkins, Baltimore (1990):1-10.
10. KREUSSER KL, TARBY TJ, KOVNAR E, TAYLOR DA, HILL A, VOLPE JJ: Serial lumbar punctures for at least temporary amelioration of neonatal posthemorrhagic hydrocephalus. Pediatrics (1985) 75:719-724.
11. AIMARD G, VIGHETTO A, GABET JY, BRET P, HENRY E: [Acetazolamide: an alternative to shunting in normal pressure hydrocephalus? Preliminary results]. Rev. Neurol. (Paris) (1990) 146:437-439.
12. MILHORAT TH: Physiology of the cerebrospinal fluid. In: Cerebrospinal fluid and the brain edemas. Neuroscience Society, New York (1987):39-73.
13. MILHORAT TH: Classification of brain swelling and edema. In: Cerebrospinal fluid and the brain edemas. Neuroscience Society, New York (1987):75-100
14. MAREN, TH: Carbonic anhydrase: chemistry. physiology, and inhibition. Physiol. Rev. (1967) 47:595-781.
15. MELDRUM NU, ROUGHTON FJW: Carbonic anhydrase: its preparation and properties. J. Physiol. (1933) 80:113-142.
16. ROUGHTON FJW: Recent work on carbon dioxide transport by the blood. Physiol. Rev. (1935) 15:241-296.
17. ASHBY W: The pattern of distribution of carbonic anhydrase in the cerebrum of man compared with that of certain of the lower animals. J. Biol. Chem. (1944) 156:323-329.
18. DAVENPORT HW: Carbonic anhydrase in tissues other than blood. Physiol. Rev. (1946) 26:560-573.
19. FISHER RG, COPENHAVER JH: The metabolic activity of the choroid plexus. J. Neurosurg. (1959) 16:167-176.
20. BIRZIS L, CARTER CH, MAREN TH: Effect of acetazolamide on CSF pressure and electrolytes in hydrocephalus. Neurology (1958) 8:522-528.
21. REKATE H, OLIVERO W: Current concepts of CSF production and absorption. In: Hydrocephalus (Vol. 3). Scott RM (Ed.), Williams & Wilkins, Baltimore (1990):11-22.
22. CSERR HF: Physiology of the choroid plexus. Physiol. Rev. (1971) 51:273-331.
23. POLLAY M, HISEY B, REYNOLDS E, TOMKINS P, STEVENS FA, SMITH R: Choroid plexus Na+/K+-activated adenosine triphosphatase and cerebrospinal fluid formation. Neurosurgery (1985) 17:768-772.
24. POLLAY M: Formation of cerebrospinal fluid. Relation of studies of isolated choroid plexus to the standing gradient hypothesis. J. Neurosurg. (1975) 42:665-673.
25. MAREN TH: Bicarbonate formation in cerebrospinal fluid: role in sodium transport and pH regulation. Am. J. Physiol. (1972) 222:885-899.
26. CARRION E, HERTZOG JH, MEDLOCK MD, HAUSER GJ, DALTON HJ: Use of acetazolamide to decrease cerebrospinal fluid production in chronically ventilated patients with ventriculopleural shunts. Arch. Dis. Child (2001) 84:68-71.
27. DAVSON H, LUCK CP: The effect of acetazolamide on the chemical composition of the aqueous humour and cerebrospinal fluid of some mammalian species and on the rate of turnover of 24Na in these fluids. J. Physiol. (1957) 137:279-293.
28. ELVIDGE AR, BRANCH CL, THOMPSON GB. Observations in a case of hydrocephalus treated with diamox. J. Neurosurg. (1957) 14:628-639.
29. ROBLIN ROJR, CLAPP JW: The preparation of heterocyclic sulfonamides. J. Amer. Chem. Soc. (1950) 72:4890-4892.
30. MAREN TH: Pharmacological and renal effects of Diamox (6063), a new carbonic anhydrase inhibitor. Trans. N. Y. Acad. Sci. (1952) 15:53.
31. MAREN TH, WADSWORTH BC, YALE EK, ALONSO LG: Carbonic anhydrase inhibition. III: effects of Diamox on electrolyte metabolism. Johns Hopk. Hosp. Bull. (1954) 95:277-321.
32. BECKER B: Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, Diamox. A preliminary report. Am. J. Ophthal. (1954) 37:13-15.
33. BECKER B: The effects of the carbonic anhydrase inhibitor, acetazolamide, on the composition of the aqueous humor. Am. J. Ophthal. (1955) 40:129-136.
34. FRIEDENWALD JS: Current studies on acetazolamide (Diamox) and aqueous humor flow. Am. J. Ophthal. (1955) 40:139-147.
35. KINSEY VE, CAMACHO E, CAVANAUGH GA, CONSTANT M: Diamox and intraocular fluid dynamics. Am. J. Ophthal. (1955) 40:147-148.
36. YANO I, TAKAYAMA A, TAKANO M et al.: Pharmacokinetics and pharmacodynamics of acetazolamide in patients with transient intraocular pressure elevation. Eur. J. Clin. Pharmacol. (1998) 54:63-68.
37. MAREN TH, ROBINSON B: The pharmacology of acetazolamide as related to cerebrospinal fluid and the treatment of hydrocephalus. Bull. Johns Hopkins. Hosp. (1960) 106:1-24.
38. MORETTI JL, BAILLET G, SZEKELY C et al.: Assessment by Tc-99m-HMPAO SPECT in patients with normal pressure hydrocephalus treated by acetazolamide. In: Textbook of SPECT in Neurology and Psychiatry. DeDeyn PP, Dierckx RA, Alavi A et al. (Eds), John Libbey & Co, London (1997):39-43.
39. ROTH LJ, BARLOW CR: Drugs in the brain. Science (1961) 134:22-31.
40. VOGH BP: The relation of choroid plexus carbonic anhydrase activity to cerebrospinal fluid formation: study of three inhibitors in cat with extrapolation to man. J. Pharmacol. Exp. Ther. (1980) 213:321-331.
41. OPPELT WW, PATLAK CS, RALL DP: Effect of certain drugs on cerebrospinal fluid production in the dog. Am. J. Physiol. (1964) 206:247-250.
42. AMES A III, HIGASHI H, NESBETT FB: Effects of pCO2, acetazolamide, and ouabain on volume and composition of choroid-plexus fluid. J. Physiol. (1965) 181:506-515.
43. FRIEDLAND BR, MALLONEE J, ANDERSON DR: Short-term dose response characteristics of acetazolamide in man. Arch. Ophthalmol. (1977) 95:1809-1812.
44. BRZEZINSKI J, KJALLQUIST A, SIESJO BK: Mean carbon dioxide tension in the brain after carbonic anhydrase inhibition. J. Physiol. (1967) 188:13-23.
45. FRIIS ML, PAULSON OB, HERTZ MM: Carbon dioxide permeability of the blood-brain barrier in man. The effect of acetazolamide. Microvasc. Res. (1980) 20:71-80.
46. GOTOH F, MEYER JS, TOMITA M: Carbonic anhydrase inhibition and cerebral venous blood gases and ions in man. Demonstration of increased oxygen availability to ischemic brain. Arch. Intern. Med. (1966) 117:39-46.
47. VORSTRUP S, HENRIKSEN L, PAULSON OB: Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen. J. Clin. Invest. (1984) 74:1634-1639.
48. LASSEN NA, FRIBERG L, KASTRUP J, RIZZI D, JENSEN JJ: Effects of acetazolamide on cerebral blood flow and brain tissue oxygenation. Postgrad. Med. J. (1987) 63:185-187.
49. SHINNAR S, GAMMON K, BERGMAN EWJ, EPSTEIN M, FREEMAN JM: Management of hydrocephalus in infancy: use of acetazolamide and furosemide to avoid cerebrospinal fluid shunts. J. Pediatr. (1985) 107:31-37.
50. HUTTENLOCHER PR: Treatment of hydrocephalus with acetazolamide. J. Pediatr. (1965) 66:1023-1030.
51. HELLER I, HALEVY J, COHEN S, THEODOR E: Significant metabolic acidosis induced by acetazolamide. Not a rare complication. Arch. Intern. Med. (1985) 145:1815-1817.
52. MARLIN AE, GASKILL SJ: The aetiology and management of hydrocephalus in the preterm infant. In: Hydrocephalus (Vol. 3). Scott RM (Ed.), Williams & Wilkins, Baltimore (1990):67-78.
53. SCHWENK MH, ST PETER WL, MEESE MG, SINGHAL PC: Acetazolamide toxicity and pharmacokinetics in patients receiving hemodialysis. Pharmacotherapy (1995) 15:522-527.
54. CHAPRON DJ, SWEENEY KR, FEIG PU, KRAMER PA: Influence of advanced age on the disposition of acetazolamide. Br. J. Clin. Pharmacol. (1985) 19:363-371.
55. CHAPRON DJ, GOMOLIN IH, SWEENEY KR: Acetazolamide blood concentrations are excessive in the elderly: propensity for acidosis and relationship to renal function. J. Clin. Pharmacol. (1989) 29:348-353.
56. EADES SK, CHRISTENSEN ML: The clinical pharmacology of loop diuretics in the pediatric patient. Pediatr. Nephrol. (1998) 12:603-616.
57. PRANDOTA J: Clinical pharmacology of furosemide in children: a supplement. Am. J. Ther. (2001) 8:275-289.
58. LORENZO AV, HORNIG G, ZAVALA LM, BOSS V, WELCH K: Furosemide lowers intracranial pressure by inhibiting CSF production. Z. Kinderchir. (1986) 41(Suppl. 1):10-12.
59. GREENE CS, JR., LORENZO AV, HORNIG G, WELCH K: The lowering of cerebral spinal fluid and brain interstitial pressure of preterm and term rabbits by furosemide. Z. Kinderchir. (1985) 40(Suppl. 1):5-8.
60. JOHANSON CE, SWEENEY SM, PARMELEE JT, EPSTEIN MH: Cotransport of sodium and chloride by the adult mammalian choroid plexus. Am. J. Physiol. (1990) 258:C211-C216.
61. JOHANSON CE, PALM DE, DYAS ML, KNUCKEY NW: Microdialysis analysis of effects of loop diuretics and acetazolamide on chloride transport from blood to CSF. Brain Res. (1994) 641:121-126.
62. INTERNATIONAL PHVD DRUG TRIAL GROUP: International randomised controlled trial of acetazolamide and furosemide in posthaemorrhagic ventricular dilatation in infancy. Lancet (1998) 352:433-440.
63. HACK M, COHEN AR: Acetazolamide plus furosemide for periventricular dilatation: lessons for drug therapy in children. Lancet (1998) 352:418-419.
64. STAFSTROM CE, GILMORE HE, KURTIN PS: Nephrocalcinosis complicating medical treatment of posthemorrhagic hydrocephalus. Pediatr. Neurol. (1992) 8:179-182.
65. SHINNAR S, GAMMON K, BERGMAN EW Jr, EPSTEIN M, FREEMAN JM: Management of hydrocephalus in infancy: use of acetazolamide and furosemide to avoid cerebrospinal fluid shunts. J. Pediatr. (1985) 107:31-37.
66. KENNEDY CR, AYERS S, CAMPBELL MJ, ELBOURNE D, HOPE P, JOHNSON A: Randomized, controlled trial of acetazolamide and furosemide in posthemorrhagic ventricular dilation in infancy: follow-up at 1 year. Pediatrics (2001) 108:597-607.
67. SCHOEMAN J, DONALD P, VAN ZYL L, KEET M, WAIT J: Tuberculous hydrocephalus: comparison of different treatments with regard to ICP, ventricular size and clinical outcome. Dev. Med. Child Neurol. (1991) 33:396-405.
68. LORBER J: Isosorbide in the medical treatment of infantile hydrocephalus. J. Neurosurg. (1973) 39:702-711.
69. HAYDEN PW, FOLTZ EL, SHURTLEFF DB: Effect of an oral osmotic agent on ventricular fluid pressure of hydrocephalic children. Pediatrics (1968) 41:955-967.
70. HAYDEN PW, SHURTLEFF DV: The medical management of hydrocephalus. Dev. Med. Child Neurol. (1972) 14:52-58.
71. SHURTLEFF DB, HAYDEN PW, WEEKS R, LAURENCE KM: Temporary treatment of hydrocephalus and myelodysplasia with isosorbide: preliminary report. J. Pediatr. (1973) 83:651-657.
72. LORBER J, SALFIELD S, LONTON T: Isosorbide in the management of infantile hydrocephalus. Dev. Med. Child Neurol. (1983) 25:502-511.
73. LORBER J: Isosorbide in treatment of infantile hydrocephalus. Arch. Dis. Child (1975) 50:431-436.
74. TAKAGI H, TANAKA M, OHWADA T, TOMONAGA F: Pharmacokinetic analysis of mannitol in relation to the decrease of ICP. In: Intracranial pressure VIII. Avezaat CJJ, van Eijndhoven JHM, Maas AIR et al. (Eds), Springer-Verlag, Berlin, Heidelberg (1993):596-600.
75. ABOU-MADI M, TROP D, RAVUSSIN P: The early role of mannitol-induced hemodynamic changes in the control of intracranial hypertension. In: Intracranial pressure VIII. Avezaat CJJ, van Eijndhoven JHM, Maas AIR et al. (Eds), Springer-Verlag, Berlin, Heidelberg (1993):601-604.
76. ABOU-MADI N, KATZ J, ABOU-MADI M, TROP D: Effects of mannitol-induced hemodynamic changes on intracranial pressure responses in dogs. In: Intracranial pressure VII. Hoff JT, Betz AL (Eds), Springer-Verlag (1989):463-465.
77. MUIZELAAR JP, LUTZ HA, BECKER DP: Effect of mannitol on ICP and CBF and correlation with pressure autoregulation in severely head-injured patients. J. Neurosurg. (1984) 61:700-706.
78. TUBBS RS, SMYTH MD, WELLONS JC III, BLOUNT JP, GRABB PA, OAKES WJ: Alternative uses for the subgaleal shunt in pediatric neurosurgery. Pediatr. Neurosurg. (2003) 39:22-24.
79. YAPICIOGLU H, NARLI N, SATAR M, SOYUPAK S, ALTUNBASAK S: Intraventricular streptokinase for the treatment of posthaemorrhagic hydrocephalus of preterm. J. Clin. Neurosci. (2003) 10:297-299.
80. ANDREWS CO, ENGELHARD HH: Fibrinolytic therapy in intraventricular hemorrhage. Ann. Pharmacother. (2001) 35:1435-1448.
81. NAFF NJ, HANLEY DF, KEYL PM et al.: Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial. Neurosurgery (2004) 54:577-583.
82. WHITELAW A, POPLE I, CHERIAN S, EVANS D, THORESEN M: Phase I trial of prevention of hydrocephalus after intraventricular hemorrhage in newborn infants by drainage, irrigation, and fibrinolytic therapy. Pediatrics (2003) 111:759-765.
83. HAINES SJ, LAPOINTE M: Fibrinolytic agents in the management of posthemorrhagic hydrocephalus in preterm infants: the evidence. Childs Nerv. Syst. (1999) 15:226-234.
84. WHITELAW A, KENNEDY CR, BRION LP: Diuretic therapy for newborn infants with posthemorrhagic ventricular dilatation. Cochrane Database Syst. Rev. CD002270, 2001.
85. WHITELAW A: Intraventricular streptokinase after intraventricular hemorrhage in newborn infants. Cochrane Database Syst. Rev. CD000498, 2001.
86. WHITELAW A: Repeated lumbar or ventricular punctures in newborns with intraventricular hemorrhage. Cochrane Database Syst. Rev. CD000216, 2001.
87. LAPOINTE M, HAINES S: Fibrinolytic therapy for intraventricular hemorrhage in adults. Cochrane Database Syst. Rev. CD003692, 2002.
88. ANWAR M, KADAM S, HIATT IM, HEGYI T: Serial lumbar punctures in prevention of posthemorrhagic hydrocephalus in preterm infants. J. Pediatr. (1985) 107:446-450.
89. DYKES FD, DUNBAR B, LAZARRA A, AHMANN PA: Posthemorrhagic hydrocephalus in high-risk preterm infants: natural history, management, and long-term outcome. J. Pediatr. (1989) 114:611-618.
90. MANTOVANI JF, PASTERNAK JF, MATHEW OP et al.: Failure of daily lumbar punctures to prevent the development of hydrocephalus following intraventricular hemorrhage. J. Pediatr. (1980) 97:278-281.
91. VENTRICULOMEGALY TRIAL GROUP: Randomised trial of early tapping in neonatal posthaemorrhagic ventricular dilatation. Arch. Dis. Child (1990) 65:3-10.
92. LIBENSON MH, KAYE EM, ROSMAN NP, GILMORE HE: Acetazolamide and furosemide for posthemorrhagic hydrocephalus of the newborn. Pediatr. Neurol. (1999) 20:185-191.
93. LUCIANO R, TORTOROLO L, CHIARETTI A, PIASTRA M, VELARDI F, POLIDORI G: Intraventricular streptokinase infusion in acute posthaemorrhagic hydrocephalus. Intens. Care Med. (1998) 24:526-529.
94. WHITTLE IR, JOHNSTON IH, BESSER M: Intracranial pressure changes in arrested hydrocephalus. J. Neurosurg. (1985) 62:77-82.
95. TORKELSON RD, LEIBROCK LG, GUSTAVSON JL, SUNDELL RR: Neurological and neuropsychological effects of cerebral spinal fluid shunting in children with assumed arrested (normal pressure) hydrocephalus. J. Neurol. Neurosurg. Phychiat. (1985) 48:799-806.
96. BRET P, CHAZAL J: Chronic ('normal pressure') hydrocephalus in childhood and adolescence. A review of 16 cases and reappraisal of the syndrome. Childs Nerv. Syst. (1995) 11:687-691.
97. POCA MA, SAHUQUILLO J, CUXART A, IBORRA J, CALZADA MD, RUBIO E: Intracranial pressure monitoring in patients with spina bifida and clinically arrested hydrocephalus. Results of a prospective study. In: Intracranial pressure IX. Nagai H, Kamiya K, Ishii S (Eds), Springer-Verlag, Tokyo (1994):604-605.
98. IBORRA J, PAGES E, CUXART A, POCA MA, SAHUQUILLO: Increased intracranial pressure in myelomeningocele (MMC) patients never shunted: results of a prospective preliminary study. Spinal Cord. (2000) 38:495-497.
99. MATARO M, POCA MA, SAHUQUILLO J et al.: Cognitive changes after cerebrospinal fluid shunting in young adults with spina bifida and assumed arrested hydrocephalus. J. Neurol. Neurosurg. Psychiatry (2000) 68:615-621.
100. PATWARDHAN RV, NANDA A: Implanted ventricular shunts in the United States: the billion-dollar-a-year cost of hydrocephalus treatment. Neurosurgery (2005) 56:139-144.